Yes, the VA covers ketamine infusion therapy, but only for specific conditions and only after you’ve tried several other treatments first. The two approved uses are treatment-resistant depression and severe neuropathic pain. If you’re hoping to get ketamine covered for PTSD, the VA currently recommends against it.
What the VA Covers Ketamine For
The VA recognizes IV ketamine as medically necessary for two conditions: treatment-resistant depression (including depression with severe suicidal ideation) and complex neuropathic pain. Each has its own set of qualifying criteria, and the bar is intentionally high. Ketamine is positioned as a later-line option after standard treatments have failed.
For PTSD specifically, the VA and Department of Defense issued joint clinical guidelines in 2023 that recommend against using ketamine. The concern is that ketamine may actually worsen PTSD symptoms. This means you won’t be able to get VA-funded ketamine therapy with a PTSD diagnosis alone, even if your PTSD hasn’t responded to other treatments.
Qualifying for Ketamine for Depression
To qualify for ketamine infusions for depression, you need to meet all of the following criteria. First, you must have a diagnosis of unipolar major depressive disorder. Bipolar depression is not included. Second, you need to have tried and failed at least four adequate trials of antidepressants from different classes over your lifetime, including at least two in your current depressive episode with an augmentation strategy. The alternative path is having severe suicidal depression where a rapid treatment response is critical.
You also need a depression severity score of 15 or higher on the PHQ-9 (a standard screening questionnaire) within the past 30 days, which corresponds to moderate or severe depression. And you need to have been evaluated for electroconvulsive therapy (ECT) as an option, though you don’t necessarily have to try it first.
In practical terms, this means ketamine won’t be your second or third treatment attempt. The VA requires that you’ve genuinely exhausted conventional antidepressants, therapy, and augmentation strategies before ketamine enters the conversation.
Qualifying for Ketamine for Chronic Pain
The pain pathway is separate from the depression pathway. You need a current diagnosis of complex regional pain syndrome or a centralized pain disorder. General chronic pain, back pain, or fibromyalgia won’t qualify on their own.
Before ketamine is considered, you must have tried and failed adequate courses of three classes of nerve pain medications: tricyclic antidepressants, certain serotonin-norepinephrine reuptake inhibitors, and gabapentinoids. A VA pain specialist with ketamine experience must evaluate you and document in your medical record that you’re a candidate. A mental health provider must also clear you, confirming there are no psychiatric contraindications.
One important distinction: ketamine for pain must be administered by a VHA pain provider at a VA facility. It cannot be referred out to a private community care provider the way depression treatment can. The VA wants to ensure ketamine is part of a broader, multi-modal pain care plan rather than a standalone treatment.
What Treatment Looks Like
The standard VA protocol for depression starts with six IV infusions spread over three weeks. If you respond well, maintenance infusions follow roughly every three weeks. Each session is administered in a clinical setting where you’re monitored throughout, since ketamine can cause temporary changes in blood pressure, dissociation, and other short-term side effects.
This isn’t a one-and-done treatment. Ketamine’s antidepressant effects tend to be temporary, which is why the maintenance schedule exists. How long the VA continues to authorize ongoing infusions depends on whether you’re showing a meaningful clinical response.
Nasal Spray Esketamine (Spravato)
Spravato, the FDA-approved nasal spray form of esketamine, is not on the VA’s national formulary. That doesn’t mean it’s impossible to get, but it does mean your provider has to submit a non-formulary drug request with prior authorization. This adds an extra approval step compared to IV ketamine. Spravato is classified as a Tier 3 copay medication, which is the highest cost-sharing tier in the VA pharmacy system.
Costs and Copays
What you’ll pay depends on your disability rating and priority group. Mental health services broadly are exempt from copays within the VA system, and readjustment counseling and related mental health services specifically carry no copay regardless of your priority group. If your ketamine treatment falls under specialty outpatient care, the standard copay rate is $50 per visit for veterans who aren’t exempt. Veterans with service-connected disabilities rated 50% or higher, or those receiving treatment for a service-connected condition, typically pay nothing.
Even for veterans who do owe a copay, VA-covered ketamine is dramatically cheaper than paying out of pocket. Private ketamine clinics typically charge $400 to $800 per infusion, and insurance coverage outside the VA is rare.
How to Start the Process
Your first step is talking to your VA mental health provider or pain specialist. They’ll assess whether you meet the clinical criteria and can initiate the referral. If your local VA medical center doesn’t have a ketamine program, the VA can authorize treatment through its Community Care network for depression (though not for pain). This means you could receive infusions at a private clinic with the VA covering the cost, provided the community care authorization and clinical criteria are both met.
Expect the approval process to take some time. You’ll need documented proof of prior treatment failures, current severity scores, and specialist evaluations in your medical record. If you’ve been treated outside the VA previously, make sure those records are available to your VA provider so they can verify your treatment history without making you repeat medication trials you’ve already been through.